In addition, CIP2A mutant mouse models showed no obvious abnormality in mouse development and viability.43 Therefore, the expression specificity and limited toxicity indicate that CIP2A inhibitors may be a hopeful therapeutic strategy for treatment of cervical cancer. Here, CIP2A is linked to cervical carcinoma.